National Heart, Lung, and Blood Institute. Expert panel report 3: guidelines for the diagnosis and management of asthma. Full report, August28, 2007. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed February 1, 2009.
2.
US Pharmacopeia. USP Dictionary of USAN and International Nonproprietary Names. Rockville, Md: US Pharmacopeia; 2009.
3.
UndemBJ. Pharmacotherapy of asthma. In: BruntonLLLazoJSParkerKL, eds. Goodman & Gilman’s the Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006:717-736.
4.
Facts & Comparisons E answers [database online]. Baltimore, Md: Wolters Kluwer Health. Accessed February 5, 2010.
5.
HendlesLColiceGLMeyerRJ. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med. 2007;356:1344-1351.
6.
Ventolin HFA® (albuterol sulfate) inhalation aerosol, 90 mcg [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2009.
Magill-LewisJ. Government-mandated inhaler switch goes into effect January 1, 2009. Drug Topics. Available at: http://drugtopics.modernmedicine.com/inhaler. Accessed February 28, 2010.
9.
Food and Drug Administration, HHS. Use of ozone-depleting substances; removal of essential-use designations: final rule. Fed Regist. 2005;70:17167-17192.